JN
Johnson & Johnson
JNJ · NYSE
$275.15 -1.18% (-$3.28)
1M +6.17%
Market Cap $671.1B
P/E Ratio 31.90x
Div. Yield 1.88%
ROE 25.74%
Bulios Fair Price
$285.49
3.8% upside
Trenutna cena
$275.15
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price se delnica JNJ trenutno trguje blizu svoje poštene vrednosti. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
8/9Valuation
30 /100
Expensive P/E 31.90x
EV/EBITDA 20.74x
P/S 6.85x
Growth
57 /100
Stable EPS growth 17.90%
Rev. growth 5.60%
FCF growth 4.65%
Profitability
100 /100
Strong Gross margin 70.45%
Net margin 21.48%
Op. margin 26.81%
Quality
79 /100
Excellent ROIC 13.89%
ROE 25.74%
ROA 10.46%
Debt
81 /100
Low Debt/Equity 0.58x
Current ratio 1.09x
Int. coverage 25.67x
Stability
47 /100
Moderate Beta 0.24x
Rev. volatility 1.15%
EPS volatility 89.73%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o JNJ
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Joaquin Duato
Employees
141,700
Headquarters
New Brunswick
Prihajajoči dogodki
13 OKT.
Earnings
Upcoming earnings report